{
    "id": 5576,
    "fullName": "ERBB3 E928G",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ERBB3 (HER3) E928G lies within the protein kinase domain of the Erbb3 (Her3) protein (UniProt.org). E928G confers a gain of Erbb3 (Her3) protein function, resulting in phosphorylation of Akt and Erk, as well as oncogenic transformation of Erbb2 (Her2) expressing cells (PMID: 23680147).",
            "references": [
                {
                    "id": 323,
                    "pubMedId": 23680147,
                    "title": "Oncogenic ERBB3 mutations in human cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23680147"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2065,
        "geneSymbol": "ERBB3",
        "terms": [
            "ERBB3",
            "c-erbB-3",
            "c-erbB3",
            "ErbB-3",
            "erbB3-S",
            "FERLK",
            "HER3",
            "LCCS2",
            "MDA-BF-1",
            "p180-ErbB3",
            "p45-sErbB3",
            "p85-sErbB3"
        ]
    },
    "variant": "E928G",
    "createDate": "04/30/2015",
    "updateDate": "04/30/2015",
    "referenceTranscriptCoordinates": {
        "id": 123464,
        "transcript": "NM_001982",
        "gDna": "chr12:g.56098849A>G",
        "cDna": "c.2783A>G",
        "protein": "p.E928G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11218,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a lobular breast carcinoma patient harboring ERBB2 (HER2) L869R and ERBB3 (HER3) E928G achieved a clinical response following treatment with Nerlynx (neratinib), and sensitivity to Nerlynx (neratinib) was also demonstrated in cells expressing ERBB2 (HER2) L869R and ERBB3 (HER3) E928G in culture (PMID: 28274957).",
            "molecularProfile": {
                "id": 27927,
                "profileName": "ERBB2 L869R ERBB3 E928G"
            },
            "therapy": {
                "id": 828,
                "therapyName": "Neratinib",
                "synonyms": null
            },
            "indication": {
                "id": 50938,
                "name": "breast lobular carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9156,
                    "pubMedId": 28274957,
                    "title": "An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28274957"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11219,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a lobular breast carcinoma patient harboring ERBB2 L869R and ERBB3 E928G demonstrated an initial response to treatment with Nerlynx (neratinib), but subsequently developed resistance, which was associated with acquisition of ERBB2 T798I (PMID: 28274957).",
            "molecularProfile": {
                "id": 27928,
                "profileName": "ERBB2 T798I ERBB2 L869R ERBB3 E928G"
            },
            "therapy": {
                "id": 828,
                "therapyName": "Neratinib",
                "synonyms": null
            },
            "indication": {
                "id": 50938,
                "name": "breast lobular carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9156,
                    "pubMedId": 28274957,
                    "title": "An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28274957"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 5407,
            "profileName": "ERBB3 E928G",
            "profileTreatmentApproaches": [
                {
                    "id": 14820,
                    "name": "HER2 Inhibitor",
                    "profileName": "ERBB3 E928G"
                },
                {
                    "id": 14821,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "ERBB3 E928G"
                },
                {
                    "id": 14823,
                    "name": "HER3 Inhibitor",
                    "profileName": "ERBB3 E928G"
                },
                {
                    "id": 14824,
                    "name": "Pertuzumab",
                    "profileName": "ERBB3 E928G"
                },
                {
                    "id": 14822,
                    "name": "Trastuzumab",
                    "profileName": "ERBB3 E928G"
                }
            ]
        },
        {
            "id": 27927,
            "profileName": "ERBB2 L869R ERBB3 E928G",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27928,
            "profileName": "ERBB2 T798I ERBB2 L869R ERBB3 E928G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 123464,
            "transcript": "NM_001982",
            "gDna": "chr12:g.56098849A>G",
            "cDna": "c.2783A>G",
            "protein": "p.E928G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}